GT801 Injection
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GT801 Injection, covering 2026-01-12 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia [EARLY_Phase 1]